Scott Rocklage – Leaving a Historical Mark on Cancer Research

Scott Rocklage, Ph.D. works with 5AM Ventures and rose to managing partner in 2004. His background is impressive. His experience includes over 30 years of managing healthcare projects. His ability to lead strategic initiatives have led to approval of three applications by the Food and Drug Administration. His background in chemistry is unquestionable.

His business accomplishments include CEO and Chairman of Cubist Pharmaceuticals, research and development positions with Salutar and Catalytica, and President and CEO of NycomedSalutar to name several. His education provides the basis for his business achievements. The University of California, Berkeley granted his Bachelor of Science degree in Chemistry. Read more: Scott Racklage | Bloomberg and Scott Racklage | Crunchbase

He received his Ph.D. in Chemistry from MIT where he conducted research under the guidance of Richard R. Schrock who won the Nobel Prize for Chemistry in 2005. Scott Rocklage is co-inventor of more than 30 United States patents.

The name 5AM Ventures, a venture capital firm that funds science-based ventures, came from the fact that the firm’s mission is to assist companies in their early stage of formation.

A typical day for Scott Rocklage may be studying life science or managing the company’s portfolio team. His days are busy and sometimes unpredictable. Working with scientists of like mind and spirit are essential for bringing his ideas to life.

He has a passion for methods that allow for the targeting of specific cancer mutations, and being able to treat them in new, unique ways. This approach and science has already saved lives. As the science improves, it will save many more lives.

The life of Scott Rocklage is the perfect example of what happens when knowledge merges with experience. One can only imagine the amazing discoveries that lie ahead.

Learn more about Scott Rocklage:

http://people.equilar.com/bio/scott-rocklage-cidara-therapeutics-/salary/913398#.WWaMA9PytTY